email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

Case Report(ISSN: 2644-1209)

Ribociclib as New Cause of Cornea Verticillata

Volume 2 - Issue 3

Alba Linero Carmen1,2*, Rocha de Lossada Carlos1, Rodríguez Calvo de Mora Marina1, De las Rivas Ramírez Nieves1, Espejo de los Riscos1 and Alba Emilio3,4

  • Author Information Open or Close
    • 1Department Ophthalmology, Hospital Civil of Málaga, Spain
    • 2Department of Ophthalmology, Faculty of Medicine of Málaga, University of Málaga, Spain
    • 3Unity of Clinical Management Intercenter of Oncology, Biomedical Research Institute of Malaga (IBIMA), Regional University Hospitals and Virgen de la Victoria, Spain
    • 4Laboratory of Molecular Biology of Cancer, Medical-Health Research Center (CIMES), University of Málaga, Spain.

    *Corresponding author: Alba-Linero Carmen, Department Ophthalmology, Faculty of Medicine of Málaga, University of Málaga, Hospital Civil of Málaga, Spain

Received:June 17, 2019;   Published:June 21, 2019

DOI: 10.32474/TOOAJ.2018.02.000138

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Our purpose is to describe the appearance of a new origin of Cornea Verticillata through a clinical case of a 67-years-old female patient with breast cancer who was being treated by Ribociclib and attended the consultation of ophthalmology by halos vision. Exploration was performed by visual acuity, slit lamp examination, fluorescein staining, retinography and corneal topography. We observed cornea verticillata in our patient, she did not need specific treatment and the findings remained stable over time.

Abstract| Introduction| Clinical Case| Discussion| Conclusion| References|

https://www.high-endrolex.com/21